The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac). The agency has determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity. As a result of this immediate market withdrawal request, ranitidine products will not be available for new or existing prescriptions or OTC use in the U.S
Related Articles
What You Should Know About the Anatomy of the Gastrointestinal System
So that it may digest and use the food you consume, your body has an extraordinary system called the gastrointestinal or GI tract. At GI Alliance, we concentrate on the health and maintenance of this important body system. Our... Read More
November Is Gastric Cancer Awareness Month
Arising nearly anywhere in the body, cancer is a concerning condition that stems from uncontrolled and abnormal cellular growth. As reported by the American Cancer Society, approximately 26,000 new stomach cancer cases develop each year. Gastric cancer, also called... Read More